Novel plasma telomerase detection method to improve cancer diagnostic assessment

• George Hilal,

  Affiliation Cancer and Metabolism Laboratory, Faculty of Medicine, Campus of Medical Sciences, Saint-Joseph University, Riad el Solh, Beirut, Lebanon

  ⨯
• Ruth Reitzel,

  Affiliation Department of Infectious Diseases, Infection Control and Employee Health, the University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Zainab Al Hamal,

  Affiliation Department of Infectious Diseases, Infection Control and Employee Health, the University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Anne-Marie Chaftari,

  Affiliation Department of Infectious Diseases, Infection Control and Employee Health, the University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Iba Al Wohoush,

  Affiliation Department of Infectious Diseases, Infection Control and Employee Health, the University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Ying Jiang,

  Affiliation Department of Infectious Diseases, Infection Control and Employee Health, the University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Ray Hachem ,

  * E-mail: rhachem@mdanderson.org

  Affiliation Department of Infectious Diseases, Infection Control and Employee Health, the University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Issam I. Raad

  Affiliation Department of Infectious Diseases, Infection Control and Employee Health, the University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯